Spencer R. Berthelsen, Director at ISIS PHARMACEUTICALS INC (ISIS), sold 20,000 shares at $9.42 ($191K) on 2012-05-21, disclosed to the SEC on 2012-05-22.
Scheduled sale ($191k) by Director under a pre-arranged 10b5-1 plan. Pre-set trade — not a discretionary signal on the stock.
Negative factors outweigh the positive ones.
| # | Price | Shares | Value | % of Total |
|---|---|---|---|---|
| 1 | $9.42 | 2,731 | $26K | 13.5% |
| 2 | $9.56 | 17,269 | $165K | 86.5% |
| Total | $9.54 avg | 20,000 | $191K | 100% |
| Filing → |
| IONS | SELL | 2024-06-20 | $645K | — | Filing → |
| IONS | SELL | 2021-06-25 | $566K | — | Filing → |
| IONS | SELL | 2020-06-25 | $881K | — | Filing → |